TrialJournal of translational medicine2011

Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib.

Charles S Harmon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.